Back to Ophthalmology
Ophthalmologyv2024Evidence-Based

Color Vision Screening (Ishihara Test)

Screens for red-green color blindness using an abbreviated 14-plate Ishihara test. Assesses the most common types of color vision deficiency in clinical practice.

Clinical Input Parameters

plates
Range: 0 — 14 plates
plates
Range: 0 — 14 plates
years
Range: 1 — 120 years
Clinical Assessment
Awaiting Parameters
color vision assessment
—assessment
Ready to Calculate

Awaiting Clinical Input

Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.

Open in Web App
Clinical decision support tool for licensed medical practitioners. Confirm independently before prescribing or clinical action.

When & Why to Use

The Color Vision Screening (Ishihara Test) is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within ophthalmology.

Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.

Clinical Formula & Scoring Logic

Scoring: >2 incorrect plates out of 14 total plates indicates color vision deficiency. Each eye is tested independently.

Clinical Pearls & Practice Notes

  • The Ishihara test is the most widely used screening tool for red-green color blindness
  • Abbreviated 14-plate version provides efficient screening while maintaining accuracy
  • Test sensitivity approximately 92%, specificity approximately 100% for red-green deficiencies
  • Less accurate for patients with visual acuity below 20/100
  • Less reliable for children under 5 years old due to attention and comprehension limitations
  • Primarily detects protanomaly (red-weak) and deuteranomaly (green-weak) color vision defects
  • Does not reliably detect tritanomaly (blue-yellow) color vision defects
  • Smartphone/tablet applications can show comparable accuracy to physical plates when properly calibrated
  • Patients with suspected color vision deficiency should be referred to ophthalmology for comprehensive evaluation
  • Consider occupational counseling for individuals with confirmed color vision deficiency
  • Not a definitive diagnostic test - formal color vision assessment may be needed
  • Can be used to screen for acute optic neuropathy (such as optic neuritis) in clinical settings

Evidence & Literature Citations

  1. Ishihara S. Tests for Colour-Blindness. Tokyo: Kanehara Trading Inc; 1917.
  2. Birch J. Worldwide prevalence of red-green color deficiency. J Opt Soc Am A Opt Image Sci Vis. 2012;29(3):313-20. doi: 10.1364/JOSAA.29.000313.
  3. Dain SJ. Clinical colour vision tests. Clin Exp Optom. 2004;87(4-5):276-93. doi: 10.1111/j.1444-0938.2004.tb05062.x.
  4. Perera C, Chakrabarti R, Islam FM, Crowston J. The Eye Phone Study: reliability and accuracy of assessing Neitz color vision with smartphone technology. Am J Ophthalmol. 2015;160(5):944-50.e1. doi: 10.1016/j.ajo.2015.08.014.

Score Interpretation Ranges

Normal12 – 14 pts

Normal color vision

Possible Deficiency8 – 11 pts

Possible color vision deficiency

Color Vision Deficiency0 – 7 pts

Color vision deficiency likely

Need Clinical Suite Access?

Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.

Open in Web App

Clinical Decision Support (CDS) Notice & Legal Disclaimer

This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.